221 related articles for article (PubMed ID: 11822535)
1. Diabetes and hypertension.
Waeber B; Feihl F; Ruilope L
Blood Press; 2001; 10(5-6):311-21. PubMed ID: 11822535
[TBL] [Abstract][Full Text] [Related]
2. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
Zanella MT; Ribeiro AB
Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
Mogensen CE
Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
[TBL] [Abstract][Full Text] [Related]
4. [Microalbuminuria is an early marker for increased morbidity and mortality].
Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
[TBL] [Abstract][Full Text] [Related]
5. [Control of arterial pressure in diabetic nephropathy].
Luño J; García de Vinuesa S
Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
[No Abstract] [Full Text] [Related]
6. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
[TBL] [Abstract][Full Text] [Related]
7. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
9. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
Coca A; Ruilope LM
Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
[No Abstract] [Full Text] [Related]
10. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
Zaoui P; Hannedouche T; Combe C
Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
Thomas MC; Atkins RC
Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
[TBL] [Abstract][Full Text] [Related]
14. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Ruilope LM; Segura J
Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
Remuzzi G; Macia M; Ruggenenti P
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
[TBL] [Abstract][Full Text] [Related]
16. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
17. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.
Bretzel RG
J Diabetes Complications; 1997; 11(2):112-22. PubMed ID: 9101397
[TBL] [Abstract][Full Text] [Related]
18. Hypertension and diabetes: the scope of the problem.
Parving HH
Blood Press Suppl; 2001; 2():25-31. PubMed ID: 11465914
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and diabetes: new therapeutic options.
Deedwania PC
Arch Intern Med; 2000 Jun; 160(11):1585-94. PubMed ID: 10847251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
